SGLT2 inhibitors and lower limb complications: an updated meta‐analysis
Chu Lin(Peking University), Linong Ji(Peking University), Xiaoling Cai(Peking University), Wenjia Yang(Peking University), Fang Lv(Liaoning Normal University), Lin Nie(Airport Shunyi District Hospital), Xingyun Zhu(Peking University)
Cited by 82
Related Papers
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Luteolin-loaded solid lipid nanoparticles synthesis, characterization, & improvement of bioavailability, pharmacokinetics in vitro and vivo studies
|Journal of Nanoparticle Research|2014|128
CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells
|Journal of Experimental & Clinical Cancer Research|2022|115